OMAHA - Researchers at the University of Nebraska Medical Center in Omaha are joining six other universities in a consortium studying new treatments for cardiovascular disease.
Dr. Irving Zucker is the principal investigator and chair of the Department of Cellular and Integrative Physiology at UNMC. He says their role will be to map out the location of nerve endings and their impact on heart disease.
Researchers believe that modulating those electrical signals holds promise as a way to treat heart problems. Zucker says this research will likely evolve over several years.
More than 80,000 people in the U.S. die each year from cardiovascular diseases such as heart failure, arrhythmia and hypertension.
Researchers believe modulating those electrical signals holds promise as a way to treat heart failure and other heart disease.